Increased IL-10+ B cell numbers in tumor tissues can also be accompanied by increased numbers of CD4+CD25+/highCD127low/− and Foxp3+ Tregs9–12, which are independently associated with tumor progression or reduced patient survival. This evidence concerns the gene IL10 and neoplasm.